Tickerplace logo

Tickerplace

Citius Oncology, Inc. logo

CTORCitius Oncology, Inc.

CTOR Stock Price, Valuation & Chart | Citius Oncology, Inc.

Compare
$0.770+0.02 (+2.94%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Drug Manufacturers - General
OverviewFinancialsDividendsRatios

CTOR Historical price chart

CTOR Key Stats

Market Capitalization71.40M
PE Ratio-1.63
EPS-0.47
Trading Volume11.70K
Today's High/Low0.77/0.75
Dividend Yield0.00
52 Week High/Low1.95/0.49
Shares Outstanding92.98M
CTOR Financial Statement
CTOR Analyst ratings
CTOR Analysis & performance metrics

CTOR Company profile

Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment…

CTOR Management team

Management
Myron S. Czuczman M.D.
Chief Medical Officer
Myron Z. Holubiak
Executive Vice Chairman & Secretary
Leonard L. MazurCEO
Chairman, Chief Executive Officer & President
Jaime BartushakCFO
Chief Financial Officer & Treasurer
Total 4 executives

CTOR Frequently asked questions

What is Citius Oncology, Inc. (CTOR) Stock Price?

Current stock price of Citius Oncology, Inc. (CTOR) stock is $0.770. The stock price is +2.94% higher in the session. The intraday range can be seen from this page. Volume of Citius Oncology, Inc. (CTOR) stock is 11.70K.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Citius Oncology, Inc. (CTOR) stock price going up or down today?

The stock price of Citius Oncology, Inc. (CTOR) can change with earnings, company news, and overall market sentiment. Citius Oncology, Inc. operates in the Healthcare / Drug Manufacturers - General market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Citius Oncology, Inc. stock expensive at its current price?

Whether Citius Oncology, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CTOR on this page is -1.63. EPS on this page is -0.47. Compare those figures with peers and growth expectations before deciding if the current Citius Oncology, Inc. price is justified.

How has the stock price of Citius Oncology, Inc. (CTOR) performed historically?

Historical performance for Citius Oncology, Inc. (CTOR) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CTOR reacted to past earnings and market events.

Should I buy Citius Oncology, Inc. (CTOR) stock, at this price?

Buying Citius Oncology, Inc. (CTOR) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.